ArticleIntegrative cancer therapies2011
Classification of CAM use and its correlates in patients with early-stage breast cancer.
Article in Integrative cancer therapies, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.
- A Systematic Review and Quality Assessment of Breast Cancer Clinical Practice Guidelines Providing Complementary and Alternative Medicine Recommendations.Current oncology reports · 2021Pooled it
- Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.Journal of the National Cancer Institute. Monographs · 2014Guideline
- Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial.Cancer · 2015Trial
- Randomized controlled trial of Qigong/Tai Chi Easy on cancer-related fatigue in breast cancer survivors.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2015Trial
- [Compliance of patients concerning recommended radiotherapy in breast cancer : Association with recurrence, age, and hormonal therapy].Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2012Trial
- Evidence-Based Perspectives on Complementary and Alternative Medicine in Cancer Treatment: Current Advances and Clinical Relevance.Journal of multidisciplinary healthcare · 2026Review
- Prevalence of late and long-term effects of cancer (treatment) and use of complementary and alternative medicine in Norway.BMC complementary medicine and therapies · 2022Article
- A Perspective on Tongue Diagnosis in Patients with Breast Cancer.Evidence-based complementary and alternative medicine : eCAM · 2021Article
- Use of GoFundMeJournal of cancer research and clinical oncology · 2020Article
- Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.Plastic surgery (Oakville, Ont.) · 2017Review
- Phytotherapy and Nutritional Supplements on Breast Cancer.BioMed research international · 2017Review
- Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.JAMA oncology · 2016Article
- Expectations from an integrative medicine consultation in breast cancer care: a registry protocol-based study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015Article
- Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.Evidence-based complementary and alternative medicine : eCAM · 2013Article
- Translation and adaptation of an international questionnaire to measure usage of complementary and alternative medicine (I-CAM-G).BMC complementary and alternative medicine · 2012Article
- Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors.Journal of women's health (2002) · 2012Article
- A Retrospective Study of Gemcitabine and Carboplatin With or Without Intravenous Vitamin C on Patients With Advanced Triple-Negative Breast Cancer.Integrative cancer therapiesArticle
- Case-based online modules to teach graduate-level nursing students about complementary and alternative medical therapies.Journal of professional nursing : official journal of the American Association of Colleges of NursingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution.
Funding
Abstract
hypothesisSelf-reported use of complementary and alternative medicine (CAM) has been shown to increase following a cancer diagnosis, and breast cancer survivors are the heaviest users among cancer survivors. The aim of this study was to determine whether the prevalence estimate of CAM use varied according to classification of CAM. The authors used a comprehensive system to classify CAM users and test differences in demographic, lifestyle, quality of life, and cancer characteristics among them. STUDY DESIGN AND
methodsParticipants were 2562 breast cancer survivors participating in the Women's Healthy Eating and Living (WHEL) Study, aged 28 to 74 years. A structured telephone interview assessed CAM use, questioning about specific CAM practices, and whether use was related to cancer. This study examined CAM use in relation to demographics, health behaviors, and quality of life.
resultsApproximately 80% of the women used CAM for general purposes but only 50% reported CAM use for cancer purposes. Visual imagery, spiritual healing, and meditation were the most frequently used practices for cancer purposes. CAM use, defined as consulting a CAM practitioner and regular use, was significantly related to younger age, higher education, increased fruit and vegetable intake, and lower body mass index (P < .05). CAM users who had seen a practitioner were also more likely to report poor physical and mental health than non-CAM users (P < .05). CAM use was not associated with changes in physical and mental health between study baseline and 1-year follow-up.
conclusionThis study addressed important differences in the classification of CAM use among breast cancer survivors. Future studies need to further test the potential benefits and risks associated with CAM use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.